arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Scilex Holding Co

SCLX
$7.02 ▲ +0.14 (+2.11%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
25 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
73
Health
Good
Bullish
auto_awesome

Analytical Summary

Scilex Holding Co shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $48.4M
Dividend Yield
Revenue Growth 72.1%
Op. Margin -373.5%
ROIC 10.2%
FCF / Share $-0.16
Trailing P/E
Price / Book
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

25-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$8.61M
↑ +72.1%
Net Income Profit after all expenses
$-45.65M
↓ -75.0%
Operating Margin Operating profit as % of sales
-373.5%
↓ -80.2%
FCF / Share Free cash flow per share
$-0.16
↓ -100.2%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
66
Returns
100
Cash Quality
22

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 6 years · 25 quarters